EVAX
Price
$2.53
Change
-$0.14 (-5.24%)
Updated
Jul 15, 04:05 PM (EDT)
Capitalization
16.87M
PROK
Price
$3.69
Change
-$0.85 (-18.72%)
Updated
Jul 14 closing price
Capitalization
477.99M
23 days until earnings call
Interact to see
Advertisement

EVAX vs PROK

Header iconEVAX vs PROK Comparison
Open Charts EVAX vs PROKBanner chart's image
Evaxion A/S
Price$2.53
Change-$0.14 (-5.24%)
Volume$1K
Capitalization16.87M
ProKidney
Price$3.69
Change-$0.85 (-18.72%)
Volume$24.46M
Capitalization477.99M
EVAX vs PROK Comparison Chart in %
Loading...
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVAX vs. PROK commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a StrongBuy and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2025
Stock price -- (EVAX: $2.67 vs. PROK: $3.69)
Brand notoriety: EVAX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 80% vs. PROK: 144%
Market capitalization -- EVAX: $16.87M vs. PROK: $477.99M
EVAX [@Biotechnology] is valued at $16.87M. PROK’s [@Biotechnology] market capitalization is $477.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • EVAX’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, EVAX is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 6 TA indicator(s) are bullish while PROK’s TA Score has 7 bullish TA indicator(s).

  • EVAX’s TA Score: 6 bullish, 2 bearish.
  • PROK’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, both EVAX and PROK are a good buy in the short-term.

Price Growth

EVAX (@Biotechnology) experienced а +16.09% price change this week, while PROK (@Biotechnology) price change was +508.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.71%. For the same industry, the average monthly price growth was +18.61%, and the average quarterly price growth was +31.65%.

Reported Earning Dates

EVAX is expected to report earnings on May 27, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($478M) has a higher market cap than EVAX($16.9M). PROK YTD gains are higher at: 118.343 vs. EVAX (-36.835). EVAX has higher annual earnings (EBITDA): -12.99M vs. PROK (-160.12M). PROK has more cash in the bank: 328M vs. EVAX (17.8M). PROK has less debt than EVAX: PROK (3.37M) vs EVAX (10.5M). EVAX has higher revenues than PROK: EVAX (3.29M) vs PROK (306K).
EVAXPROKEVAX / PROK
Capitalization16.9M478M4%
EBITDA-12.99M-160.12M8%
Gain YTD-36.835118.343-31%
P/E RatioN/AN/A-
Revenue3.29M306K1,076%
Total Cash17.8M328M5%
Total Debt10.5M3.37M312%
TECHNICAL ANALYSIS
Technical Analysis
EVAXPROK
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 6 days ago
72%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSVYX18.28N/A
N/A
MassMutual Small Cap Opps Svc
GGCCX97.64N/A
N/A
Gabelli Growth C
FGRAX50.66N/A
N/A
Franklin Growth Opportunities A
LFGCX36.85N/A
N/A
Lord Abbett Focused Growth C
MSVDX5.45N/A
N/A
Morgan Stanley Vitality Portfolio I

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with NRIX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-18.72%
NRIX - PROK
39%
Loosely correlated
+2.01%
CGON - PROK
39%
Loosely correlated
-3.07%
APGE - PROK
38%
Loosely correlated
+1.94%
CGEM - PROK
37%
Loosely correlated
+2.21%
KYMR - PROK
37%
Loosely correlated
+0.94%
More